Seeing Is Believing

Currently out of the existing stock ratings of Yale Jen, 54 are a BUY (98.18%), 1 are a HOLD (1.82%).
Analyst Yale Jen, currently employed at LAIDLAW, carries an average stock price target met ratio of 27.03% that have a potential upside of 42.95% achieved within 349 days.
Yale Jen’s has documented 106 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARCT, Arcturus Therapeutics Holdings at 22-Oct-2025.
Analyst best performing recommendations are on CRIS (CURIS).
The best stock recommendation documented was for CRIS (CURIS) at 12/8/2020. The price target of $200 was fulfilled within 31 days with a profit of $69 (52.67%) receiving and performance score of 16.99.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jan-2025
$20
$6.97 (53.49%)
$23
14 days ago
(24-Sep-2026)
0/5 (0%)
$5.88 (41.64%)
Hold Since 13-Nov-2025
$20
$6.97 (53.49%)
$8
14 days ago
(24-Sep-2026)
7/14 (50%)
$5.88 (41.64%)
142
Buy Since 02-Jul-2026
$27
$13.15 (94.95%)
3 months 6 days ago
(02-Jul-2026)
0/1 (0%)
$19.72 (270.88%)
Hold Since 18-Mar-2026
$22
$15.12 (219.77%)
$23
6 months 20 days ago
(18-Mar-2026)
6/7 (85.71%)
$15.45 (235.88%)
99
Buy Since 07-Feb-2020
$21
$14.12 (205.23%)
7 months 3 days ago
(05-Mar-2026)
1/7 (14.29%)
$13.75 (189.66%)
75
What Year was the first public recommendation made by Yale Jen?